FDA Inspection
University of Texas MD Anderson Cancer CenterUniversity of Texas MD Anderson Cancer Center – FDA Inspection, Oct 26, 2017
Record Details
This FDA Inspection record concerns University of Texas MD Anderson Cancer Center, with an inspection on October 26, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- October 26, 2017
- Product Type
- Biologics
View Company Profile
ID · d787b14f-8a35-4532-833e-d9891b6fabcf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1030030
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.60(a)Equipment observed, standardized, calibrated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of University of Texas MD Anderson Cancer Center
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 24, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for University of Texas MD Anderson Cancer Center
- FDA Inspection 1167810 - 2022-03-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.